Effect of nebulized formoterol, ipratropium bromide, and furosemide in combination with fluticasone propionate on arterial blood gases of premature calves with respiratory distress syndrome

PDF
DOI: https://doi.org/10.12681/jhvms.22949
Keywords:
arterial blood gases nebulized drugs respiratory treatment premature calves
M. OK
Department of Internal Medicine, Faculty of Veterinary Medicine, Selçuk University, Konya, Turkey
R. YILDIZ
Department of Internal Medicine, Faculty of Veterinary Medicine, Mehmet Akif Ersoy University, Burdur, Turkey
B. TRAŞ
Department of Pharmacology and Toxicology, Faculty of Veterinary Medicine, Selçuk University, Konya, Turkey
N. BAŞPINAR
Department of Biochemistry, Faculty of Veterinary Medicine, Selçuk University, Konya, Turkey
A. AKAR
Department of Internal Medicine, Faculty of Veterinary Medicine, Mehmet Akif Ersoy University, Burdur, Turkey
Abstract

The purpose of this study was to assess the clinical effect of nebulized formoterol (FM), ipratropium bromide (IB) and furosemide (FS) combined with fluticasone propionate (FP) on l ung function in premature calves with Respiratory Distress Syndrome (RDS). Thirty-six premature calves with RDS were randomly assigned to six different treatment groups (D1 to D6). All groups received the standard treatment, including oxygen and support treatment. Calves in D1 received only the standard treatment. The following combinations of nebulized drugs were used for the other groups: D2: FP, D3: FP+FM; D4: FP+IB; D5: FP+FS and D6: FP+IB+FM+FS. The treatment period (72 h) involved the application of FM (15 μg totally/12 h), IB (2 μg/kg/12 h), FS (1 mg/kg/12 h) and FP (15 μg/kg/12 h) for five minutes. A significant increase over time in blood pH, partial pressure of oxygen (PaO2), oxygen saturation (SatO2) and a decrease in partial pressure of carbon dioxide (PaCO2) and lactate were detected in all groups that received nebulized treatment; while in the D1, a significant change was observed only for PaCO2. Calves in D6 had the highest PaO2 and lowest PaCO2 values amongst all groups at the end of treatment. No statistical difference was observed between the Nebulization Groups (NG). Nebulized FM, IB and FS with FP combination in premature calves with RDS, in addition to the standard treatment showed a significant curative effect on lung function.

Article Details
  • Section
  • Research Articles
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Authors who publish with this journal agree to the following terms:

· Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution Non-Commercial License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.

· Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g. post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.

· Authors are permitted and encouraged to post their work online (preferably in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.

Downloads
Download data is not yet available.
References
Aydogdu U, Yildiz R, Guzelbektes H, Coskun A, Sen I (2016) Cardiac biomarkers in premature calves with respiratory distress syndrome. Acta Vet Hung. 64(1): 38-46.
Bancalari E, Wilson-Costello D, Iben SC (2005) Management of infants with bronchopulmonary dysplasia in North America. Early Hum Dev. 81(2): 171-179.
Bleul U (2009) Respiratory distress syndrome in calves. Vet Clin Food Anim. 25(1): 179-193.
Bleul U, Lejeune B, Schwantag S, Kähn W (2007) Blood gas and acid-base analysis of arterial blood in 57 newborn calves. Vet Rec. 161(20): 688-691.
Bleul UT, Bircher BM., Kahn WK (2008) Effect of intranasal oxygen administration on blood gas variables and outcome in neonatal calves with respiratory distress syndrome: 20 cases (2004-2006). J Am Vet Med Assoc. 233(2): 289-293.
Broadstone RV, Robinson NE, Gray PR, Woods PSA, Derksen FJ (1991) Effects of furosemide on ponies with recurrent airway obstruction. Pulm Pharmacol. 4(4): 203-208.
Chhabra SK, Vijayan VK, Vasu T (2006) Inhaled formoterol versus ipratropium bromide in chronic obstructive pulmonary disease. Indian J Chest Dis Allied Sci. 48(2): 97-102.
Coghe J, Uystepruyst CH, Bureau F, Detilleux J, Art T, Lekeux P (2000) Validation and prognostic value of plasma lactate measurement in bovine respiratory disease. Vet J. 160(2): 139-146.
Duvivier DH, Bayly WM, Votion D, Vandenput S, Art T, Farnir F, Lekeux P (1999) Effects of inhaled dry powder ipratropium bromide on recovery from exercise of horses with COPD. Equine Vet J. 31(2): 20-24.
Faulds D, Hollingshead L Formoterol (1991) A review of its pharmacological properties and therapeutic potential in reversible obstructive airways disease. Drugs. 42(1): 115-137.
Genicot B, Mouligneau F, Close R, Lekeux P (1994) Functional effects of a muscarinic receptor blockade during acute respiratory distress syndrome in double-muscled calves. Vet Rec. 134(4): 110-113.
Güzelbekteş H, Coskun A, Ok M, Aydogdu U, Sen I (2012) Prevalence of gastroesophageal reflux disease in premature calves. J Vet Intern Med. 26(4): 1051-1055.
Jarjour NN, Wilson SJ, Koening SM, Laviolette M, Moore WC, Davis WB, Ramsdell JW (2006) Control of airway inflammation maintained at lower steroid dose with 100/50 microg of fluticasone propionate/salmeterol. J Allergy Clin Immun. 118(1): 44-52.
Leemans J, Kirschvink N, Bernearts F, Clercx C, Cambier C, Gustin P (2009) A pilot study comparing the antispasmodic effects of inhaled salmeteol, salbutomol and ipratropium bromide using different aerosol devices on muscarinic bronchoconstriction in healthy cats. Vet J. 180(2): 236-245.
Murch SH, Costeloe K, Klein NJ, MacDonald TT (1996) Early production of macrophage inflammatory protein-1 alpha occurs in respiratory distress syndrome and is associated with poor outcome. Pediatr Res. 40(3): 490-497.
Ok M, Birdane FM (2000) Blood acid-base status and some blood gases and electrolytes levels in premature calves. Vet Bil Derg. 16(1): 147-150.
Palmer JE (2005) Ventilatory support of the critically ill foal. Vet Clin North Am Equine Pract. 21(2): 457-486.
Robinson NE, Berney C, Behan A, Derksen FJ (2009) Fluticasone propionate aerosol is more effective for prevention than treatment of recurrent airway obstruction. Vet Intern Med. 23(6): 1247-1253.
Sahni J, Phelps SJ (2011) Nebulized furosemide in the treatment of bronchopulmonary dysplasia in preterm infants. J Pediatr Pharmacol Ther. 16(1): 14-22.
Verder H, Albertsen P, Ebbesen F, Greisen G, Robertson B, Bertelsen A, Reinholdt J (1999) Nasal continuous positive airway pressure and early surfactant therapy for respiratory distress syndrome in newborns of less than 30 weeks’ gestation. Pediatrics. 103(2): 24.
Yildiz R, Aydogdu U, Guzelbektes H, Coskun A, Sen I (2017) Venous lactate, pH and partial pressure of carbon dioxide levels as prognostic indicators in 110 premature calves with respiratory distress syndrome. Vet Rec. 180(25): 611.
Yildiz R, Ok M (2017) Clinical efficacy of combinations of nebulised fluticasone, salbutamol and furosemide on lung function in premature calves with respiratory distress syndrome. Vet Med Czech. 62(10):541-552.
Zhang W, Fievez L, Zhang F, Cheu E, Antoine N, Delguste C, Gustin P (2010) Effects of formoterol and ipratropium bromide on repeated cadmium inhalation-induced pulmonary inflammation and emphysema in rats. Eur J Pharmacol. 647(1-3): 178-187.
Most read articles by the same author(s)